Company Filing History:
Years Active: 2022
Title: John Herman Collett: Innovator in Plasma Kallikrein Inhibition
Introduction
John Herman Collett is a notable inventor based in Flintshire, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of oral solid dosage forms. His work focuses on innovative solutions that address medical needs through advanced formulations.
Latest Patents
Collett holds a patent for "Dosage forms comprising a plasma kallikrein inhibitor." This invention relates to oral solid dosage forms that include a plasma kallikrein inhibitor, specifically a solid form (Form 1) of the compound of Formula A. The patent also outlines methods for preparing these oral solid dosage forms using Form 1 of the compound of Formula A.
Career Highlights
Collett is associated with Kalvista Pharmaceuticals Limited, a company dedicated to advancing therapeutic solutions. His role at the company has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry.
Collaborations
Collett has worked alongside talented individuals such as Gary Paul Cook and Jamie Joseph Farrar. Their collaborative efforts have further enhanced the innovative capabilities within their field.
Conclusion
John Herman Collett's work exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly in plasma kallikrein inhibition, highlight the importance of research and development in creating effective medical solutions.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.